HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers.

AuthorsRamaswamy Manikandan, Rahul Mistry, Joe Philip, Philip Cornford
JournalBJU international (BJU Int) Vol. 97 Issue 3 Pg. 653 (Mar 2006) ISSN: 1464-4096 [Print] England
PMID16469048 (Publication Type: Letter, Comment)
Chemical References
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
Topics
  • Bone Neoplasms (drug therapy, secondary)
  • Bone Resorption (drug therapy)
  • Diphosphonates (adverse effects, therapeutic use)
  • Humans
  • Imidazoles (adverse effects, therapeutic use)
  • Magnesium Deficiency (chemically induced)
  • Urogenital Neoplasms
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: